TrialScientific reports2016

Adenovirally-Induced Polyfunctional T Cells Do Not Necessarily Recognize the Infected Target: Lessons from a Phase I Trial of the AERAS-402 Vaccine.

Melissa Nyendak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.